Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InfuSystem Holdings, IncINFU · Entity 6163 | Director | May 12, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InfuSystem Holdings, Inc
Report date May 12, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.37 · Expires 2036-05-12 | Direct | 24,890 |
Reported balance
After 2026-05-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-12 · Grant · Acquired 24,890 · Balance 24,890 F1: The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027. |
| Common StockSEC Table I · non-derivative | Direct | 70,000 |
Reported balance
Holding disclosure · report date 2026-05-12 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 70,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2026 Filed May 14, 2026 22:29 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 24,890 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001628280-26-035259 · wk-form4_1778797754.xml · derivative · entry 2 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,890 Underlying: Common Stock · 24,890 shares Expires 2036-05-12 F1 · derivative.exercise_date: The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027. Read SEC document |
| May 08, 2026 Filed May 12, 2026 13:31 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 5,000 | $8.88 | $44,400.00 |
DisclosureSEC source: 0001628280-26-033911 · wk-form4_1778592663.xml · nonDerivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 16, 2025 Filed May 20, 2025 22:54 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 39,588 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026954 · wk-form4_1747781689.xml · derivative · entry 2 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,588 Underlying: Common Stock · 39,588 shares Expires 2035-05-16 F1 · derivative.exercise_date: The option, representing the right to purchase 39,588 shares of InfuSystem Holdings, Inc. common stock, vests on May 16, 2026. Read SEC document |
| May 20, 2024 Filed May 21, 2024 22:09 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 5,000 | $6.54 | $32,700.00 |
DisclosureSEC source: 0001628280-24-024587 · wk-form4_1716329375.xml · nonDerivative · entry 2 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Read SEC document |
| May 17, 2024 Filed May 21, 2024 22:09 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 35,685 | $0.00 Strike: $6.34 | $0.00 |
DisclosureSEC source: 0001628280-24-024587 · wk-form4_1716329375.xml · derivative · entry 3 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,685 Underlying: Common Stock · 35,685 shares Expires 2034-05-17 F1 · shares: The option, representing the right to purchase 35,685 shares of InfuSystem Holdings, Inc. common stock, vests on May 17, 2025. Read SEC document |
| May 18, 2023 Filed May 19, 2023 21:00 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Options (right to buy) · Derivative | 24,424 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001628280-23-019115 · wf-form4_168452999025397.xml · derivative · entry 2 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,424 Underlying: Common Stock · 24,424 shares Expires 2033-05-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 24,424 shares of InfuSystem Holdings, Inc. common stock, vests on May 18, 2024. Read SEC document |
| May 17, 2022 Filed May 17, 2022 21:08 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001628280-22-014654 · wf-form4_165282164473442.xml · derivative · entry 2 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-05-17 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2021 Equity Plan, which is computed as the closing price of the Company's common stock reported on the NYSE American LLC on the date of grant. F2 · derivative.exercise_date: The option, representing the right to purchase 25,000 shares of InfuSystem Holdings, Inc. common stock, vests on the date of the 2023 annual shareholder meeting. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 23:35 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 10,000 | $10.67 | $106,700.00 |
DisclosureSEC source: 0001014108-22-000061 · primary_doc.xml · nonDerivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:38 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | Exercise / conversionStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001014108-21-000194 · primary_doc.xml · derivative · entry 2 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2024-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 23:38 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | Exercise / conversionCommon Stock | 25,000 | $4.70 | $117,500.00 |
DisclosureSEC source: 0001014108-21-000194 · primary_doc.xml · nonDerivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 21, 2021 01:30 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $19.50 | $0.00 |
DisclosureSEC source: 0001014108-21-000114 · primary_doc.xml · derivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2021-05-18 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 18, 2021. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 22:27 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 3,000 | $20.34 | $61,020.00 |
DisclosureSEC source: 0001014108-21-000089 · primary_doc.xml · nonDerivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 20, 2020 Filed May 22, 2020 23:49 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $11.07 | $0.00 |
DisclosureSEC source: 0001014108-20-000073 · primary_doc.xml · derivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-05-20 F1 · derivative.exercise_price: The stock option was issued with an exercise price equal to the Fair Value as defined by the 2014 Equity Plan, which is computed as the average closing price of the Company's common stock reported on the NYSE American LLC for the five (5) most recent trading days prior to the date of grant. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning June 20, 2020. Read SEC document |
| March 23, 2020 Filed Mar 25, 2020 18:27 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 10,000 | $5.77 | $57,700.00 |
DisclosureSEC source: 0001014108-20-000044 · primary_doc.xml · nonDerivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.55 to 5.99, inclusive. The Reporting Person undertakes to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| May 15, 2019 Filed May 16, 2019 15:09 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $4.70 | $0.00 |
DisclosureSEC source: 0001437749-19-010171 · rdgdoc.xml · derivative · entry 1 GENDRON PAUL ANDREW · CIK 0001769450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-05-15 F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve equal monthly installments beginning on June 15, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.